tirzepatide 15 mg weight loss associated with greater in women than men Tirzepatide Dosing for Weight Loss

The most significant risk factor is concurrent use of insulin or insulin secretagogues, including sulfonylureas (such as glimepiride, glyburide, or glipizide) and meglitinides

Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

What happens then

At Boca Medical Care, we understand that managing type 2 diabetes can be challenging

The provider documents class 3 obesity, BMI 41.2, and starts a GLP-1 medication

Our medical weight loss program and GLP-1 treatment options are supervised by Dr